1.A Case of Cyclopia Associated with Trisomy 13.
Ji Hae SEOK ; Seong Wook CHUNG ; Seong Kweon SON ; Ri Ra LEE ; Deok Hi LEE ; In Koo KANG ; Ik Soo KIM
Korean Journal of Obstetrics and Gynecology 1999;42(8):1839-1843
Cyclopia is rare congenital craniofacial anomaly, in which the eyes are fused together and located in a single orbit. It is consistently associated with severe holoprosencephaly, which is the failure of cleavage of the prosencephalon with a deficit in the midline facial development. chromosomal study revealed 47, X( ), +13 (Patau syndrome).
Holoprosencephaly
;
Orbit
;
Prosencephalon
;
Trisomy*
2.Fulminant course in a case of malignant phyllodes tumor.
Young Woo CHANG ; Hwan Soo KIM ; Deok Woo KIM ; Gil Soo SON
Annals of Surgical Treatment and Research 2017;92(2):110-112
We present the case of a 31-year-old woman with an inflammatory and ulcerative malignant phyllodes tumor in her right breast. A right modified radical mastectomy and transverse rectus abdominis myocutaneous (TRAM) flap were performed. A month after the initial operation, several masses recurred at the superior margin and deep margin of the TRAM flap. Wide excision was performed, but masses recurred at the inferior margin and in both lung fields 2 weeks after the second operation. Six weeks after the second operation, the patient died due to progression of dyspnea and respiratory failure.
Adult
;
Breast
;
Breast Neoplasms
;
Dyspnea
;
Female
;
Humans
;
Lung
;
Mastectomy, Modified Radical
;
Phyllodes Tumor*
;
Rectus Abdominis
;
Respiratory Insufficiency
;
Ulcer
3.Differential Chemokine Signature between Human Preadipocytes and Adipocytes.
Rosa Mistica C IGNACIO ; Carla R GIBBS ; Eun Sook LEE ; Deok Soo SON
Immune Network 2016;16(3):189-194
Obesity is characterized as an accumulation of adipose tissue mass represented by chronic, low-grade inflammation. Obesity-derived inflammation involves chemokines as important regulators contributing to the pathophysiology of obesity-related diseases such as cardiovascular disease, diabetes and some cancers. The obesity-driven chemokine network is poorly understood. Here, we identified the profiles of chemokine signature between human preadipocytes and adipocytes, using PCR arrays and qRT-PCR. Both preadipocytes and adipocytes showed absent or low levels in chemokine receptors in spite of some changes. On the other hand, the chemokine levels of CCL2, CCL7-8, CCL11, CXCL1-3, CXCL6 and CXCL10-11 were dominantly expressed in preadipocytes compared to adipocytes. Interestingly, CXCL14 was the most dominant chemokine expressed in adipocytes compared to preadipocytes. Moreover, there is significantly higher protein level of CXCL14 in conditioned media from adipocytes. In addition, we analyzed the data of the chemokine signatures in adipocytes obtained from healthy lean and obese postmenopausal women based on Gene Expression Omnibus (GEO) dataset. Adipocytes from obese individuals had significantly higher levels in chemokine signature as follows: CCL2, CCL13, CCL18-19, CCL23, CCL26, CXCL1, CXCL3 and CXCL14, as compared to those from lean ones. Also, among the chemokine networks, CXCL14 appeared to be the highest levels in adipocytes from both lean and obese women. Taken together, these results identify CXCL14 as an important chemokine induced during adipogenesis, requiring further research elucidating its potential therapeutic benefits in obesity.
Adipocytes*
;
Adipogenesis
;
Adipose Tissue
;
Cardiovascular Diseases
;
Chemokines
;
Culture Media, Conditioned
;
Dataset
;
Female
;
Gene Expression
;
Hand
;
Humans*
;
Inflammation
;
Obesity
;
Polymerase Chain Reaction
;
Receptors, Chemokine
4.Potential Roles of Innate Immune Chemokine and Cytokine Network on Lipopolysaccharide-Based Therapeutic Approach in Ovarian Cancer
Rosa Mistica C IGNACIO ; Eun Sook LEE ; Deok Soo SON
Immune Network 2019;19(3):e22-
Ovarian cancer (OC), the deadliest gynecological cancer, results in poor overall survival, urgently requiring a novel therapeutic approach. As cumulative exposures to endotoxins decreased OC risk epidemiologically, we evaluated if LPS, a Toll-like receptor 4 agonist known as active component of endotoxins, could increase survival in the murine peritoneal dissemination model of SKOV-3 OC cells. LPS significantly increased the mean survival time of more than 116 days compared with 63 days in the control. Furthermore, no tumor burden was present in three mice among eight LPS-treated mice. SKOV-3 cells were not responsive to LPS and showed unaltered chemokine signature. Rather than direct effects to OC cells, LPS was found to increase proinflammatory chemokines and cytokines, such as CXCL1, CXCL8, TNF, and IL-1B, in innate immune system. Taken together, LPS is likely to potentiate the cytotoxic-related innate immunogenicity via proinflammatory chemokines and cytokines, which attenuates the peritoneal dissemination of OC.
Animals
;
Chemokines
;
Cytokines
;
Endotoxins
;
Immune System
;
Immunity, Innate
;
Lipopolysaccharides
;
Mice
;
Ovarian Neoplasms
;
Survival Rate
;
Toll-Like Receptor 4
;
Tumor Burden
5.The Antitumor Potentials of Benzimidazole Anthelmintics as Repurposing Drugs
Deok-Soo SON ; Eun-Sook LEE ; Samuel E ADUNYAH
Immune Network 2020;20(4):e29-
The development of refractory tumor cells limits therapeutic efficacy in cancer by activating mechanisms that promote cellular proliferation, migration, invasion, metastasis, and survival. Benzimidazole anthelmintics have broad-spectrum action to remove parasites both in human and veterinary medicine. In addition to being antiparasitic agents, benzimidazole anthelmintics are known to exert anticancer activities, such as the disruption of microtubule polymerization, the induction of apoptosis, cell cycle (G2/M) arrest, anti-angiogenesis, and blockage of glucose transport. These antitumorigenic effects even extend to cancer cells resistant to approved therapies and when in combination with conventional therapeutics, enhance anticancer efficacy and hold promise as adjuvants. Above all, these anthelmintics may offer a broad, safe spectrum to treat cancer, as demonstrated by their long history of use as antiparasitic agents. The present review summarizes central literature regarding the anticancer effects of benzimidazole anthelmintics, including albendazole, parbendazole, fenbendazole, mebendazole, oxibendazole, oxfendazole, ricobendazole, and flubendazole in cancer cell lines, animal tumor models, and clinical trials. This review provides valuable information on how to improve the quality of life in patients with cancers by increasing the treatment options and decreasing side effects from conventional therapy.
6.Orthognathic surgery on Skeletal Class III patiens with collapsed vertical dimension: case report.
Youn Kyung CHOI ; Yong Deok KIM ; Soo Byung PARK ; Yong Il KIM ; Seong Sik KIM ; Woo Sung SON
Journal of Dental Rehabilitation and Applied Science 2016;32(1):70-79
Patients who lost posterior teeth due to periodontitis or dental caries have collapsed vertical dimension, unstable occlusion and change of the mandibular position. In particular, patients in orthognathic surgery, clinician should re-establish the pre-operative stable position of mandibular condyle in articular fossa and favorable vertical dimension for high post-operative stability of mandible. Therefore, interdisciplinary approach and co-operation, including prosthetics, orthodontics, oral and maxillofacial surgeon, from diagnosis and treatment plan is important to get a good outcome. This case report was patients who had collapsed occlusal plane due to severe dental caries on maxillary molars with skeletal Class III malocclusion. Before orthognathic surgery, resetting of maxillary occlusal plane with temporary removable denture was performed. Then successful multidisciplinary approach was done and lead to acceptable clinical outcome.
Dental Caries
;
Dental Occlusion
;
Dentures
;
Diagnosis
;
Humans
;
Malocclusion
;
Mandible
;
Mandibular Condyle
;
Molar
;
Orthodontics
;
Orthognathic Surgery*
;
Periodontitis
;
Tooth
;
Vertical Dimension*
7.Localization of Serum Amyloid A3 in the Mouse Ovary.
Hyeongjwa CHOI ; Rosa Mistica C. IGNACIO ; Eun Sook LEE ; Katherine F ROBY ; Paul F TERRANOVA ; Deok Soo SON
Immune Network 2017;17(4):261-268
Tumor necrosis factor-α (TNF-α) induces serum amyloid A (SAA) 3 among acute-phase proteins in mouse granulosa cells by activating NF-κB signaling via p55 TNF-α receptor type 1. However, the localization of SAA3 within the ovary is unknown. Here we investigated ovarian localization of SAA3 in a mouse ovulation model and in response to IL-1β, a proinflammatory mediator. For the ovulation model, equine chorionic gonadotropin (eCG; 2.5 IU) was administered to mice subcutaneously (sc) to stimulate follicular development on day 25 of age and then 50 h after eCG, human chorionic gonadotropin (hCG; 2.5 IU) was administered sc to induce ovulation. The mouse ovulation model was characterized by the localization of CYP19 mRNA expression to granulosa layers of larger follicles. SAA3 mRNA, determined by in situ hybridization, was broadly expressed throughout the whole ovary. Granulosa layers and small follicles expressed higher SAA3 mRNA compared to thecal-interstitial layers and large follicles, respectively. Interestingly, atretic follicles contained cells expressing intense SAA3 mRNA. After ovulation, SAA3 mRNA expression was intensely evident in ruptured follicles and corpora lutea (CL). The intraperitoneal administration of IL-1β revealed the intense and extensive appearance of specific cells expressing SAA3 mRNA around follicles and in CL. In addition, Gene Expression Omnibus (GEO) database analysis supported expression pattern of SAA3 mRNA observed in mouse ovulation model. Taken together, SAA3 was broadly distributed through the whole ovary, but intensely expressed in atretic follicles and CL. Furthermore, proinflammatory mediators could trigger the intense appearance of SAA3 around follicles and in CL.
Acute-Phase Proteins
;
Amyloid*
;
Animals
;
Aromatase
;
Chorionic Gonadotropin
;
Corpus Luteum
;
Electrocardiography
;
Female
;
Gene Expression
;
Granulosa Cells
;
In Situ Hybridization
;
Mice*
;
Necrosis
;
Ovarian Follicle
;
Ovary*
;
Ovulation
;
RNA, Messenger
;
Serum Amyloid A Protein
8.Augmented Serum Amyloid A1/2 Mediated by TNF-induced NF-κB in Human Serous Ovarian Epithelial Tumors.
Hyeongjwa CHOI ; Rosa Mistica C IGNACIO ; Eun Sook LEE ; Andrew J WILSON ; Dineo KHABELE ; Deok Soo SON
Immune Network 2017;17(2):121-127
Tumor necrosis factor-α (TNF) is well known to be involved in the immune system and ovarian inflammation. Ovarian cancer is an inflammation-related malignancy that lacks early screening strategies, resulting in late diagnosis followed by high mortality. Based on our previous data, TNF induced abundant serum amyloid A (SAA), an acute phase protein linked to inflammation, in ovarian granulosal cells. To date, the regulation and expression of SAA in ovarian cancer is not fully elucidated. Here, we investigated the relationship between TNF and SAA by comparing human normal ovarian tissues and serous ovarian tumors. We found that SAA1/2 was significantly expressed in tumor tissues, but no or trace expression levels in normal tissues. TNF was also significantly upregulated in ovarian tumor tissues compared to normal tissues. Moreover, TNF significantly increased SAA1/2 levels in human ovarian cancer cell lines, OVCAR-3 and SKOV-3, in a time-dependent manner. Since the SAA1 promoter contains two nuclear factor (NF)-κB sites, we examined whether TNF regulates SAA1 promoter activity. Deletion analysis revealed that the proximal NF-κB site (−95/−85) played a critical role in regulating TNF-induced SAA1 promoter activity. Within 2 h after intraperitoneal injection of lipopolysaccharide, a product known to stimulate release of TNF, SAA preferably localized to ovarian epithelial cells and the thecal-interstitial layers compared to granulosal cell layers. Based on Gene Expression Omnibus (GEO) database, SAA1/2 and TNF were dominantly expressed in advanced grade ovarian cancer. Taken together, the accumulation of SAA1/2 in ovarian cancer could be mediated by TNF-induced NF-κB activation.
Acute-Phase Proteins
;
Amyloid*
;
Cell Line
;
Delayed Diagnosis
;
Epithelial Cells
;
Gene Expression
;
Humans*
;
Immune System
;
Inflammation
;
Injections, Intraperitoneal
;
Mass Screening
;
Mortality
;
Necrosis
;
Ovarian Neoplasms
;
Serum Amyloid A Protein
;
Tumor Necrosis Factor-alpha
9.A Case of EBV-associated Hemophagocytic Lymphohistiocytosis with Seizure and Loss of Consciousness.
Hye Cheon JEONG ; Deok Soo KIM ; Won Seop KIM ; Sang Hoon CHA ; Il Heon BAE ; Kyeong Seob SHIN ; Bo Ra SON ; Hyeon Jin PARK
Journal of the Korean Child Neurology Society 2002;10(2):325-332
Hemophagocytic lymphohistiocytosis(HLH) is a rare and fatal disorder in children. Persistent fever, hepatosplenomegaly and pancytopenia are observed in the most cases with the characteristic change of serum triglyceride, fibrinogen, ferritin and LDH level. CNS manifestation were developed in 50-70% of HLH. 20% of cases revealed seizure and irritability at diagnosis. Abnormalities on brain imaging, such as diffuse white matter abnormalities and necrotic area with parenchymal volume loss appeared to roughly parallel the severity of clinical manifestations. In HLH, EBV is the major triggering agent inducing hemophagocytosis as well as the fulminant course of disease. Many cases of EBV-HLH had monoclonal origin and respond well to etoposide-containing regimens. Early induction of an etoposide based regimen is critical factor in securing long-term survival in patients with EBV-HLH. We report a case that 13 year-old female patient with seizure and loss of consciousness was diagnosed as EBV-HLH and treated with protocol HLH-94 consistd of etoposide, dexamethasone, cyclosporin.
Adolescent
;
Central Nervous System
;
Child
;
Cyclosporine
;
Dexamethasone
;
Diagnosis
;
Etoposide
;
Female
;
Ferritins
;
Fever
;
Fibrinogen
;
Herpesvirus 4, Human
;
Humans
;
Lymphohistiocytosis, Hemophagocytic*
;
Neuroimaging
;
Pancytopenia
;
Seizures*
;
Triglycerides
;
Unconsciousness*
10.A Clinical Anatomic Study of Internal Mammary Perforators as Recipient Vessels for Breast Reconstruction.
In Soo BAEK ; Jae Pil YOU ; Sung Mi RHEE ; Gil Su SON ; Deok Woo KIM ; Eun Sang DHONG ; Seung Ha PARK ; Eul Sik YOON
Archives of Plastic Surgery 2013;40(6):761-765
BACKGROUND: Partially resecting ribs of the recipient site to facilitate easy anastomosis of the internal mammary vessels to free flaps during breast reconstruction can cause chest wall pain or deformities. To avoid this, the intercostal perforating branches of the internal mammary vessels can be used for anastomosis. The purpose of this study was to investigate the location and size of the internal mammary perforator vessels based on clinical intraoperative findings and to determine their reliability as recipient vessels for breast reconstruction with microsurgical free tissue transfer. METHODS: Twelve patients were preoperatively screened for the presence of internal mammary perforators using Doppler tracing. After modified radical mastectomy was performed by a general surgeon, the location and size of the internal mammary perforator vessels were microscopically investigated. The external diameter was examined using a vessel-measuring gauge from a mechanical coupling device, and the distance from the mid-sternal line to the perforator was also measured. RESULTS: The largest arterial perforator averaged 1.5 mm, and the largest venous perforator averaged 2.2 mm. Perforators emerging from the second intercostal space had the largest average external diameter; the second intercostal space also had the largest number of perforators arising from it. The average distance from the mid-sternal line to the perforator was 20.2 mm. CONCLUSIONS: Internal mammary perforators presented consistent and reliable anatomy in this study. Based on these results, the internal mammary perforators appear to have a suitable diameter for microvascular anastomosis and should be considered as an alternative recipient vessel to the internal mammary vessel.
Breast Neoplasms
;
Breast*
;
Congenital Abnormalities
;
Female
;
Free Tissue Flaps
;
Humans
;
Mammaplasty*
;
Mammary Arteries
;
Mastectomy
;
Mastectomy, Modified Radical
;
Ribs
;
Thoracic Wall